Physician profile
Neil Fine
NPI 1841226719
$7,124.28
in general payments reported to CMS, 2019-2025
26 companies · $609 in 2025
The $609 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,847 · 2020: $327 · 2021: $1,399 · 2022: $738 · 2023: $498 · 2024: $706 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,065.97 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $816.60 | 2021 | |
| Mentor Worldwide LLC | $556.94 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Merz North America, INC. | $511.31 | 2019-2022 | |
| Tepha INC | $501.54 | 2019 | |
| Sientra, INC. | $373.33 | 2019-2022 | |
| Acera Surgical, INC. | $326.18 | 2024 | Restrata Wound Matrix |
| Davol INC. | $264.38 | 2022-2024 | Arista Ah Flexitip |
| Musculoskeletal Transplant Foundation INC. | $207.93 | 2019-2025 | |
| Abbvie INC. | $203.30 | 2023-2025 | |
| Rti Surgical, INC | $199.98 | 2025 | |
| Innovation Technologies INC | $195.90 | 2023 | Irrisept |
| Polynovo North America LLC | $168.74 | 2024 | Novosorb Btm |
| Kerecis Limited | $147.35 | 2022 | |
| Avita Medical Americas, LLC | $141.09 | 2025 | Recell, Cohealyx, Permeaderm |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $121.64 | 2019 | |
| Tela Bio, INC. | $50.57 | 2021 | |
| Motiva USA, LLC | $45.46 | 2024 | |
| Galderma Laboratories, L.P. | $43.59 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $38.44 | 2019 | |
| W. L. Gore & Associates, INC. | $36.85 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Integra Lifesciences Corporation | $32.55 | 2023 | Durasorb Monofilament Mesh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.35 | 2019 | |
| Axogen | $20.38 | 2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Sanara Medtech INC. | $17.95 | 2023 | Celleraterx |
| Coopersurgical, INC. | $13.96 | 2025 | Insorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Fine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.